Stock listing

EVT Stock Price, News, Filings & Events — Evotec Se

Selected listing: EVT · GETTEX · EUR · DE

This page tracks Evotec Se's EVT:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EVT:GETTEX. EVT:GETTEX is the stock-level entry point for investors researching Evotec Se, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Evotec SE is a public company listed on the German market under the ticker EVT. With a market capitalization of approximately €1.01 billion, Evotec focuses on drug discovery and development services. The company collaborates with various partners to advance innovative therapies and improve patient outcomes.

EVT:GETTEXEURDEUpdated August 28, 2026
Evotec Se logo
Ticker
EVT:GETTEX
Asset type
Stock
Market cap
$700.5M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
GETTEX
Currency
EUR

Evotec Se EVT:GETTEX stock context

This page tracks Evotec Se's EVT:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EVT:GETTEX. EVT:GETTEX is the stock-level entry point for investors researching Evotec Se, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Evotec SE is a public company listed on the German market under the ticker EVT. With a market capitalization of approximately €1.01 billion, Evotec focuses on drug discovery and development services. The company collaborates with various partners to advance innovative therapies and improve patient outcomes.

Latest news from Evotec Se

All Evotec Se news →

Evotec Se earnings calls

Research Evotec Se

Alternate listings